OMICSingular Genomics Systems, ...

Nasdaq singulargenomics.com


$ 9.00 $ -0.32 (-3.43 %)    

Friday, 28-Jun-2024 15:38:07 EDT
QQQ $ 479.98 $ -3.41 (-0.71 %)
DIA $ 391.11 $ -0.45 (-0.11 %)
SPY $ 544.70 $ -1.67 (-0.31 %)
TLT $ 91.77 $ -1.75 (-1.87 %)
GLD $ 215.03 $ 0.04 (0.02 %)
$ 8.45
$ 9.00
$ 0.00 x 0
$ 0.00 x 0
$ 9.00 - $ 9.00
$ 7.53 - $ 31.50
23,541
na
22.97M
$ 2.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-18-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 goldman-sachs-maintains-neutral-on-singular-genomics-sys-lowers-price-target-to-075

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...

 singular-genomics-sys-q1-eps-034-beats-035-estimate-sales-44200k-beat-39000k-estimate

Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of...

 singular-genomics-sys-q4-2023-gaap-eps-032-beats-036-estimate-sales-1081m-beat-731333k-estimate

Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of...

 earnings-scheduled-for-march-18-2024

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

 singular-genomics-showcases-new-g4x-spatial-sequencer-at-agbt-and-announces-significant-advances-in-throughput-quality-and-usability-for-g4-sequencing-platform

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomi...

 goldman-sachs-maintains-neutral-on-singular-genomics-sys-lowers-price-target-to-085

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...

 goldman-sachs-maintains-neutral-on-singular-genomics-sys-lowers-price-target-to-085

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target...

 singular-genomics-reports-instrument-shipments-and-preliminary-unaudited-q4-2023-revenue-sees-q4-revenue-of-1m-vs-765k-yoy

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics techn...

 singular-genomics-sys-q3-2023-eps-031-beats-038-estimate-sales-46200k-miss-127m-estimate

Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 why-invo-bioscience-shares-are-trading-higher-by-over-31-here-are-20-stocks-moving-premarket

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third...